Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients

BACKGROUND: With the progress of precision medicine treatment in pancreatic ductal adenocarcinoma (PDAC), individualized cancer-related medical examination and prediction are of great importance in this high malignant tumor and tumor-immune microenvironment with changed pathways highly enrolled in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Deyu, Wang, Meiqi, Peng, Lisi, Yang, Xiaoli, Li, Keliang, Yin, Hua, Xia, Chuanchao, Cui, Fang, Huang, Haojie, Jin, Zhendong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723862/
https://www.ncbi.nlm.nih.gov/pubmed/34987579
http://dx.doi.org/10.1155/2021/4986227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723862/
https://www.ncbi.nlm.nih.gov/pubmed/34987579
http://dx.doi.org/10.1155/2021/4986227

Ejemplares similares